This is a routine insider sale notice; no material market impact expected. Monitor for any acceleration of insider selling, but this filing alone does not warrant action.
TVTX drugs
TVTX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 5 $44.80entry
- T+1 · 7mo ago 0.00%α −1.38% · $44.80
- T+5 · 6mo ago −2.88%α −4.86% · $43.51
- T+20 · 6mo ago −4.11%α −9.06% · $42.96
- T+60 · 4mo ago +27.86%α +25.12% · $57.28
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Elizabeth Reed, an officer of Travere Therapeutics, filed a Form 144 to sell 20,000 shares of common stock valued at approximately $900,000, acquired via stock option exercise. The sale is part of ongoing insider selling, but the amount relative to market cap is small and not material.
Key Facts
- Elizabeth Reed (officer) intends to sell 20,000 shares
- Estimated value of $900,000
- Shares acquired via stock option exercise
- Sale to be executed through Morgan Stanley
Financial Impact
Not specified
Risk Factors
- Potential further insider selling
- Stock option exercises may signal insider sentiment if large relative to holdings
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003951 |
| Document: 0001950047-26-003951-index.html | 0001950047-26-003951 |
| Document: 0001950047-26-003951.txt | 0001950047-26-003951 |
Track record
21 reports on TVTX
8 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +56.24% at T+60 after the Jun 2, 2026 report. 10 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $50.30 Now $49.70 −1.19% settles Nov 23
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $48.87 to $51.56 Now $49.70 +1.70% ▲ +5.50% +2.21% vs SPY
- Nov 3, 202613d ago Institutional Cluster Bullish 4/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
- Nov 2, 202614d ago 8-K Bullish 6/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
- Sep 17, 20268w ago Insider Cluster Bearish 4/10 Entry $62.76 to $59.44 Now $49.70 +20.81% ▲ +5.29% +6.56% vs SPY
- Jul 9, 202618w ago 8-K Neutral 2/10 Entry $56.59 to $55.28 Now $49.70 −12.18% ▼ −2.31% −1.75% vs SPY
- Jun 16, 202621w ago Insider Cluster Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
- Jun 16, 202621w ago 8-K Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
- Jun 12, 202622w ago 144 Neutral 2/10 Entry $52.04 to $55.15 Now $49.70 −4.50% ▲ +5.98% +5.30% vs SPY
- Jun 2, 202623w ago 8-K Bullish 6/10 Entry $42.96 to $48.57 Now $49.70 +15.69% ▲ +13.06% +16.02% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers